Laila Dåvøy believes the state should pay the bill for ME-patients that want to be tested for the XMRV-virus. Laila Dåvøy (KrF) thinks the findings of the XMRV-virus in Norwegian ME patients is exciting. Now she wants the state to provide financial support so more can be tested.
With the grand opening Monday of the Center for Molecular Medicine at the University of Nevada, Reno, the world has gained another powerful weapon in the fight against diseases that cripple and kill millions of people every year, one of the new center’s key researchers said.
Two Reno scientists, who last year discovered a new infectious human retrovirus they linked to Chronic Fatigue Syndrome, said Monday that their findings have been replicated and confirmed by the U.S. Food and Drug Administration.
Denmark’s first ME/CFS conference was held on May 28th, 2010. See it on DVD.
We, the Think Tank panel of ESME, applaud the actions of the task force and again call for a similar ban to be issued in all European countries. Until the connection between XMRV and ME/CFS is fully understood, it is strongly advisable to prohibit donations of blood and blood components from these patients and irresponsible to act otherwise. We encourage you to contact your government officials and ask them to ban ME/CFS patients from donating blood.
Available Presentations of the IPFA/PEI 17th Workshop on "Surveillance and Screening of Blood Borne Pathogens", 26 - 27 May 2010
We (FDA & NIH) have independently confirmed the Lombardi group findings.
Gendringen (NL) – June 22, 2010. The FDA and the NIH have independently confirmed the XMRV findings as published in Science, October last. This confirmation was issued by Dr. Harvey Alter of the NIH during a closed workshop on blood transfusion held on May 26-27 in Zagreb. Two journalists from the Dutch magazine for health professionals, ORTHO, who have been working on XMRV stories for several months, were able to obtain a copy of the Alter lecture.
Judy A. Mikovits1,* and Francis W. Ruscetti2 We reported the detection of the human gammaretrovirus XMRV in 67% of 101 patients with chronic fatigue syndrome (CFS) and in 3.7% of 218 healthy controls, but we did not claim that XMRV causes CFS. Here, we explain why the criticisms of Sudlow et al., Lloyd et al., and van der Meer et al. regarding the selection of patients and controls in our study are unwarranted. 1 Whittemore Peterson Institute, Reno, NV 89557, USA. 2 Laboratory of Experimental Immunology, National Cancer Institute–Frederick, Frederick, MD 21701, USA. * To whom correspondence should be addressed. E-mail: judym@wpinstitute.org
ESME.com is designed, developed and hosted by Norsk Kunde & Medlemsutvikling